Sunday September 05 , 2010
Font Size
   

eEye

eEye Digital Security

RETINA

NETWORK SECURITY SCANNER

  • Integrated Threat and Security Management
  • Vulnerability Assessment Across your Entire Network
  • Automated Audit Updates Three Times Faster Than the Leading Competitor
  • Asset Classification including Rogue, Mobile, and Virtual Machines
  • Policy and Regulatory Compliance and Best Practice Recommendations for Security

RETINA

WEB SECURITY SCANNER

  • Vulnerability Assessment for Web Applications
  • Fully Automated Web Crawling and Assessment
  • No Website Training or Learning Required
  • Most Accurate Scanning Tool on the Market
  • Supports Credentials, Proxies, and Custom Applications
  • Policy and Regulatory Compliance and Best Practice Recommendations for Web Security

BLINK 4.0

  • Integrated virus, spyware, identity theft, and malware protection
  • Combines multiple security products into one solution
  • Protects against both known and zero day vulnerabilities
  • Advanced network and application protection with host based intrusion prevention and buffer overflow protection technologies
  • Allows organizations to maintain protection outside of change control windows
  • Highly scalable with the REM Security Management Console for centralized policy control and enterprise wide reporting®

 

ENTERPRISE EDITIONS

  • Centralized Enterprise Security Management and Reporting for eEye Solutions
  • Monitor, administer, and report on enterprise security vulnerabilities, attacks, and assets from the only single web based command center in the industry
  • Monitor and manage security events across multiple sites and scale to a multi-tier architecture for any size organization as software or appliance
  • Manage security policies, document exceptions, and enforce regulatory compliance for PCI, FDCC, HIPAA, SOX, GLB, and FISMA
  • Integrate with Retina Network Security Scanner and Blink Endpoint Protection Platform for a comprehensive security infrastructure that has been independently tested with a false positive rate of less than 1%